February 2023 - Page 2 of 3 - PsychedelicNewsWire (PNW)

WednesdayFeb 15, 2023 12:46 pm

More States Join Push for Psychedelics Policy Reform

Psychedelics have become very popular amid the reform movement. Legislators in different states across the country have even introduced measures to decriminalize and legalize psychedelics in an effort to stop criminalizing individuals over these drugs as well as allow their recreational and medicinal use. Numerous studies have shown that psychedelics such as psilocybin and MDMA could be useful in the treatment of mental health conditions, including anxiety, depression and post-traumatic stress disorder. Below, we look at some of the latest developments on policy reform in different states thus far. Missouri Last week, Senator Thompson Rehder introduced a measure that would…

TuesdayFeb 14, 2023 1:50 pm

Tim Ferris, Other Notables to Attend Denver Psychedelics Conference

After decades of prohibition by most territories, psychedelics are finally seeing a surge in interest among the scientific and mainstream communities. Initial research into the potential risks and benefits of psychedelic drugs has revealed that they may be able to alleviate the symptoms of a variety of mental health disorders. While this research is still in its infancy, it has shown that psychedelics have significant potential as mental health treatment, especially when paired with psychotherapy. Stakeholders, entrepreneurs and anyone else interested in psychedelics will have the chance to learn everything about them during the upcoming Psychedelic Sciences conference. The conference…

MondayFeb 13, 2023 1:34 pm

Psychedelics Are Proving Their Mettle Against Trauma, Anxiety

The past two decades have been characterized by numerous drug reform initiatives that have resulted in controlled substances such as cannabis and psychedelics being recognized for their medical potential. While there has been a decent amount of research into cannabis thanks to loosening reforms across the country, psychedelic research is still in its infancy. Despite this limited research, hallucinogens have exhibited immense potential as treatments against a variety of mental health conditions in initial studies. The result has been a surge of research into the potential benefits and risks of using psychedelics to treat mental disorders such as depression, post-traumatic…

FridayFeb 10, 2023 12:08 pm

UC Davis Launches Institute for Psychedelic Studies

After decades of criminalization by federal and state governments, psychedelics are finally seeing their day in the sun. Early research into psychedelics carried out in the late 1950s and early 1960s revealed that these substances may have some mental health benefits, but criminalization prevented researchers from studying hallucinogenic drugs further. In recent years, a renaissance of psychedelic research has shown that these drugs can have profound and long-term benefits in the treatment of several mental health conditions, especially when they are paired with psychotherapy. This has resulted in a flurry of action among institutions across the world. Big Pharma and…

ThursdayFeb 09, 2023 1:04 pm

Study Links Use of Classic Psychedelics to Positive Behaviors

Psychedelics have been getting an inordinate amount of media attention in recent years due to their medical potential. Although federal law forbids the production, sale and use of psychedelics, loosening policies have allowed researchers to conduct more research on hallucinogenic drugs such as psilocybin and MDMA. Initial research has revealed that these and other psychedelics may be able to alleviate symptoms of moderate to severe mental health disorders when paired with psychotherapy. As such, lawmakers in several states and even other nations such as Australia are working to loosen the restrictions on psychedelics and allow more research. A study that…

WednesdayFeb 08, 2023 1:18 pm

Australia First in Line to Categorize Psychedelics as Medicinal

Australia recently made history when it categorized psychedelics as medicines, becoming the first country in the world to grant the distinction to hallucinogenic drugs. Psychedelics have been subject to an increasing amount of research in recent years amid a rising push for alternative mental health treatments. Hallucinogenic drugs such as psilocybin and ketamine have exhibited a range of potential medical benefits against mental health disorders in a variety of clinical trials. However, the fact that these substances are largely illegal worldwide has hindered further research and made it nearly impossible for people who could benefit from psychedelic-assisted therapies to access…

TuesdayFeb 07, 2023 12:47 pm

Colorado Governor Announces Psychedelic Advisory Board Membership

At the start of the year, the Colorado Department of Regulatory Agencies (DORA) began searching for individuals to join an advisory board that would be responsible for informing on psychedelic policy. As part of those efforts, DORA promoted a web page where interested professionals could fill out applications to join the state’s first-ever Medicine Advisory Board. Nearly a month later, Colorado governor Jared Polis announced the appointment of 15 members to the Natural Medicine Advisory Board. The 15-member board will be tasked with studying and making recommendations on matters related to psychedelics law. Voters in Colorado voted in favor of…

MondayFeb 06, 2023 11:28 am

Research Highlights Possibility of Trip-Free Psychedelics

Psychedelics are poised to revolutionize the psychiatric industry over the next few decades. This is because initial research into hallucinogenic drugs has revealed that they may be able to alleviate the symptoms of mental health disorders such as post-traumatic stress disorder. Studies have found that even a single dose of a psychedelic, such as ketamine and psilocybin, can result in long-term benefits without most of the side effects typically seen in pharmaceutical mental health drugs. However, these hallucinogenic drugs are still psychoactive despite their therapeutic benefits, and patients usually have to go through a guided psychedelic experience, or “trip,” once…

FridayFeb 03, 2023 11:12 am

Senators in Virginia Approve Measure Rescheduling Psilocybin

Drug reform supporters in Virginia recently secured a major win after Virginia senators voted in favor of a psilocybin-rescheduling bill. The initiative, introduced by Senator Ghazala Hashmi, would reschedule psilocybin to a lower schedule and establish a psilocybin advisory board to oversee the study of the psychedelic’s therapeutic potential. The bill received overwhelming approval from the Senate Education and Health Subcommittee on Health Professions and passed after a 6 to 1 vote in its favor. Interestingly, the legislation, which will now advance to the full committee for further consideration, is a narrower version of a bill Hashmi filed during the…

ThursdayFeb 02, 2023 12:44 pm

Why You Shouldn’t Worry About Addiction Risk in Ketamine Infusions

The past couple of years have seen a surge in psychedelic research that has revealed potential therapeutic benefits in using hallucinogenic drugs such as ketamine and psilocybin to treat mental health issues. Although most of this research is in its infancy due to prohibitionist laws that have prevented psychedelic research for decades, the findings are extremely promising. Researchers have found that even a single dose of a psychedelic such as ketamine can result in profound and long-lasting mental health benefits. As such, Big Pharma and investors are pouring millions of dollars into the research and development of psychedelic-assisted therapies. With…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050

Month: February 2023